IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | -50.0% | 44 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $2,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $2,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $2,000 | -33.3% | 44 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $3,000 | -76.9% | 44 | -83.5% | 0.00% | -81.8% |
Q1 2020 | $13,000 | 0.0% | 267 | +25.9% | 0.01% | +10.0% |
Q4 2019 | $13,000 | -18.8% | 212 | -20.3% | 0.01% | -33.3% |
Q3 2019 | $16,000 | -5.9% | 266 | 0.0% | 0.02% | 0.0% |
Q2 2019 | $17,000 | +6.2% | 266 | +28.5% | 0.02% | +25.0% |
Q1 2019 | $16,000 | +77.8% | 207 | +18.3% | 0.01% | +71.4% |
Q4 2018 | $9,000 | – | 175 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |